News stories about Health Net (NYSE:HNT) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Health Net earned a media sentiment score of 0.18 on Accern’s scale. Accern also gave media headlines about the healthcare company an impact score of 44.6710956374202 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Shares of Health Net (HNT) remained flat at $$67.19 on Friday. Health Net has a 12 month low of $52.40 and a 12 month high of $76.67.

WARNING: This story was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/12/02/health-net-hnt-earns-news-sentiment-rating-of-0-18.html.

About Health Net

Health Net, Inc (Health Net) is a managed care organization. The Company provides managed health care services through health plans and government-sponsored managed care plans. Its segments are Western Region Operations and Government Contracts. It provides and administers health benefits to approximately 6 million individuals across the United States through group, individual, Medicare, Medicaid, dual eligible, the United States Department of Defense (Department of Defense or DoD), including TRICARE, and the United States Department of Veterans Affairs programs.

Insider Buying and Selling by Quarter for Health Net (NYSE:HNT)

Receive News & Stock Ratings for Health Net Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Net Inc. and related stocks with our FREE daily email newsletter.